Patents by Inventor Mieko Shiwa

Mieko Shiwa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of diagnosing nephrotic syndrome
    Publication number: 20050260678
    Abstract: This invention provides organic biomolecule markers (e.g., proteins) useful for differentiating minimal change nephrotic syndrome (MCNS) from focal segmental glomerulosclerosis (FCS), membranous nephrothropy (MN), and membranoproliferative glomerulonephritis (MPGN). This invention also provides organic biomolecule markers useful for evaluating the therapeutic value of agents for treating kidney disease.
    Type: Application
    Filed: August 29, 2002
    Publication date: November 24, 2005
    Inventors: Naohisa Tomosugi, Mieko Shiwa, Kenji Saito
  • Novel proteome analysis method and devices therefor
    Publication number: 20030129666
    Abstract: The present invention provides a proteome analysis method including grouping a proteome into membrane proteins and compounds capable of interacting with the membrane proteins, while retaining their native structure and function, and analyzing both the membrane proteins and the compounds based on biological affinity, and devices therefore.
    Type: Application
    Filed: October 4, 2002
    Publication date: July 10, 2003
    Applicant: Mitsubishi Pharma Corporation
    Inventors: Kenji Tanaka, Lyang-ja Lee, Hiromichi Mukai, Koji Munechika, Hisashi Arikuni, Mieko Shiwa, Bungo Ochiai
  • Novel proteome analysis method and devices therefor
    Publication number: 20030044843
    Abstract: The present invention provides a proteome analysis method including grouping a proteome into membrane proteins and compounds capable of interacting with the membrane proteins, while retaining their native structure and function, and analyzing both the membrane proteins and the compounds based on biological affinity, and devices therefor.
    Type: Application
    Filed: January 3, 2002
    Publication date: March 6, 2003
    Applicant: Mitsubishi Pharma Corporation
    Inventors: Kenji Tanaka, Lyang-ja Lee, Hiromichi Mukai, Koji Munechika, Hisashi Arikuni, Mieko Shiwa, Bungo Ochiai